Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemical Recurrence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT03440411
What this trial is testing

Pom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Treatment

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 9
Large-scale testing (Phase 3)Study completedNCT00779402
What this trial is testing

PROvenge Treatment and Early Cancer Treatment

Who this might be right for
Prostate Cancer
Dendreon 176
Not applicableLooking for participantsNCT03920033
What this trial is testing

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy

Who this might be right for
Prostate CancerBiochemical RecurrenceRadiation+5 more
Asan Medical Center 288
Large-scale testing (Phase 3)Active Not RecruitingNCT05794906
What this trial is testing

Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Who this might be right for
Biochemically Recurrent Prostate Cancer
Bayer 985
Large-scale testing (Phase 3)UnknownNCT04734184
What this trial is testing

A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Curium PET France 217
Testing effectiveness (Phase 2)Study completedNCT02206503
What this trial is testing

Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 13
Not applicableStudy completedNCT07655648
What this trial is testing

Dual-tracer PET Radiomics for Prostate Cancer Stratification

Who this might be right for
Prostate CancerGleason ScorePET/CT+2 more
Xiangya Hospital of Central South University 100
Testing effectiveness (Phase 2)Study completedNCT03572387
What this trial is testing

A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment

Who this might be right for
Prostatic NeoplasmsProstate NeoplasmsProstate Cancer
Icahn School of Medicine at Mount Sinai 14
Post-approval studies (Phase 4)Study completedNCT01087008
What this trial is testing

Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 103
Large-scale testing (Phase 3)UnknownNCT05847348
What this trial is testing

68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of ProstateProstate CancerBCR Prostate Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 110
Not applicableStudy completedNCT03527199
What this trial is testing

Prostate Cancer Patients With Biochemical Recurrence

Who this might be right for
Patients With Prostate Cancer
Medhat Osman 65
Large-scale testing (Phase 3)Study completedNCT02578940
What this trial is testing

Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer

Who this might be right for
Cancer of the Prostate
Blue Earth Diagnostics 104
Not applicableLooking for participantsNCT06941363
What this trial is testing

Salvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence

Who this might be right for
Prostate Cancer (Post Prostatectomy)
University of Milano Bicocca 50
Testing effectiveness (Phase 2)Ended earlyNCT00670046
What this trial is testing

Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Large-scale testing (Phase 3)Not Yet RecruitingNCT05232578
What this trial is testing

Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness

Who this might be right for
Prostate Cancer
General University Hospital, Prague 380
Large-scale testing (Phase 3)Study completedNCT00138008
What this trial is testing

Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy

Who this might be right for
Prostate Cancer
Haruhiko Fukuda 200
Large-scale testing (Phase 3)Study completedNCT06235099
What this trial is testing

Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaBiochemical Recurrence of Malignant Neoplasm of Prostate
Curium US LLC 235
Not applicableUnknownNCT04870567
What this trial is testing

HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer

Who this might be right for
Biochemical Relapse Free SurvivalComplications Rates (Erectile Dysfunction, GI, GU Complications)
N.N. Petrov National Medical Research Center of Oncology 350
Not applicableLooking for participantsNCT07792993
What this trial is testing

Focal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy

Who this might be right for
Localized Prostate Cancer
Regina Elena Cancer Institute 82
Testing effectiveness (Phase 2)Study completedNCT00596895
What this trial is testing

Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer

Who this might be right for
Biochemical Recurrent Prostate Cancer
University of Florida 20
Next Page